MKI67 and urinary bladder carcinoma: Large scale studies showed MKI67 to be a valuable biomarker for outcome prediction in localized urothelial carcinoma but provided in advanced bladder cancer no additional information in comparison to tumor stage in advanced bladder cancer [43, 44].